文献速递复苏、休克与脓毒症心脑血管急症

成人心脏骤停期间使用血管升压药:系统评价与荟萃分析

Vasopressors during adult cardiac arrest: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2019-04-10
一句话结论对照试验数据提示肾上腺素可改善院外心脏骤停的自主循环恢复、出院存活和3个月存活,不可电击心律的短期获益更明显;与肾上腺素单用相比,血管升压素联合或不联合肾上腺素均无获益。

该系统评价遵循PRISMA,检索Medline、Embase、Web of Science、CINAHL和Cochrane Library的对照试验与观察性研究,纳入成人任何场景的心脏骤停,共纳入15项对照试验和67项观察性研究,多数仅涉及院外心脏骤停。对肾上腺素 vs 安慰剂(2项对照试验)、血管升压素 vs 肾上腺素(3项)、肾上腺素+血管升压素 vs 肾上腺素单用(3项)进行荟萃分析。对照试验数据提示肾上腺素改善院外心脏骤停的自主循环恢复、出院存活和3个月存活,短期结局改善在不可电击心律中更明显;长期神经功能结局差异未达统计学显著,但有改善信号。对照试验数据表明血管升压素联合或不联合肾上腺素相比肾上腺素单用无获益。

要点

  • 对照试验数据提示肾上腺素改善院外心脏骤停的自主循环恢复、出院存活和3个月存活。
  • 肾上腺素对短期结局的改善在不可电击心律中似乎更明显。
  • 长期神经功能结局差异未达统计学显著,但有改善信号。
  • 对照试验数据表明血管升压素联合或不联合肾上腺素相比肾上腺素单用无获益。
  • 观察性研究的偏倚风险总体为 критически 严重或严重,主要源于混杂和选择偏倚。

适用人群与场景

  • 成人任何场景的心脏骤停;多数纳入研究仅涉及院外心脏骤停。

研究设计与关键结果

  • 系统评价与荟萃分析,遵循PRISMA,纳入15项对照试验和67项观察性研究。
  • 多数研究仅涉及院外心脏骤停。
  • 对照试验数据提示肾上腺素改善院外心脏骤停的自主循环恢复、出院存活和3个月存活。
  • 肾上腺素对短期结局的改善在不可电击心律中似乎更明显。
  • 长期神经功能结局差异未达统计学显著,但有改善信号。
  • 对照试验数据表明血管升压素联合或不联合肾上腺素相比肾上腺素单用无获益。
  • 对照试验偏倚风险为低至有一些担忧,证据确定性从极低到高;观察性研究偏倚风险总体为严重或严重,主要源于混杂和选择偏倚。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入对照试验和观察性研究。
  • 证据确定性采用GRADE评估,范围从极低到高。
  • 对照试验偏倚风险为低至有一些担忧;观察性研究偏倚风险总体为严重或严重,主要源于混杂和选择偏倚。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为对照试验数据提示肾上腺素改善院外心脏骤停的自主循环恢复、出院存活和3个月存活,短期结局改善在不可电击心律中似乎更明显。
  • 作者认为长期神经功能结局差异未达统计学显著,但有改善信号。
  • 作者认为对照试验数据表明血管升压素联合或不联合肾上腺素相比肾上腺素单用无获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To systematically review the literature on the use of vasopressors during adult cardiac arrest to inform an update of international guidelines.

METHODS: PRISMA guidelines were followed. We searched Medline, Embase, Web of Science, CINAHL, and the Cochrane Library for controlled trials and observational studies. The population included adults with cardiac arrest in any setting. Pairs of investigators reviewed studies for relevance, extracted data, and assessed the risk of bias for individual studies. Certainty of evidence was evaluated using GRADE for controlled trials and meta-analyses were performed when at least two studies could be pooled.

RESULTS: We included 15 controlled trials and 67 observational studies. The majority of studies included out-of-hospital cardiac arrest only. Meta-analyses were performed for two controlled trials comparing epinephrine to placebo, three comparing vasopressin to epinephrine, and three comparing epinephrine plus vasopressin to epinephrine only. All controlled trials ranged between low to some concern in risk of bias. The certainty of evidence ranged from very low to high. Risk of bias for observational studies was generally critical or serious, largely due to confounding and selection bias.

CONCLUSIONS: Controlled trial data suggest that epinephrine improves return of spontaneous circulation, survival to hospital discharge, and 3-month survival in out-of-hospital cardiac arrest. The improvement in short-term outcomes appeared more pronounced for non-shockable rhythms. Differences in long-term neurological outcome did not reach statistical significance, although there was a signal toward improved outcomes. Controlled trial data indicated no benefit from vasopressin with or without epinephrine compared to epinephrine only.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Holmberg MJ, Issa MS, Moskowitz A, et al. Vasopressors during adult cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2019. PMID: 30980877. doi:10.1016/j.resuscitation.2019.04.008

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。